While artificial intelligence semiconductors ($NVDA) and mega-cap technology indices ($QQQ) have dominated headline market returns, institutional portfolio managers are quietly rotating significant capital into a surging contrarian sector: Biotechnology and Healthcare Innovation ETFs. Powered by breakthrough clinical trial approvals, AI-accelerated drug discovery, and a wave of...
